Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001969223-24-000918
Filing Date
2024-12-13
Accepted
2024-12-13 12:13:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3388
  Complete submission text file 0001969223-24-000918.txt   4838
Mailing Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878
Business Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Subject) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-26770 | Film No.: 241547443
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O GLYCOMIMETICS, INC. 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879
Business Address
King Rachel K. (Reporting) CIK: 0001589712 (see all company filings)

Type: 144